Radnor Capital Partners – Moves into Life Sciences, Liz Klein joins the team
Radnor Capital Partners is pleased to announce that Elizabeth Klein has joined the team as a Senior Consultant. Throughout her twenty year career as a top ranked Life Sciences analyst, Liz has developed a deep understanding of the companies and investors in the Life Science sector. Liz also has considerable experience in advising clients on all aspects of their capital markets strategy; from equity fundraising to investor messaging.
Liz holds a First Class Degree in Applied Biology with Genetics, an MA in Medicine, Science & Society, and an MBA. Liz started her City career in 1995 at D E Shaw, subsequently moving to Dresdner Kleinwort, RW Baird, Bridgewell. In 2015, Liz left N+1 Singer to set up her own consultancy, Klein-Edmonds Associates. For much of her City career, Liz was Top 10 ranked in the Extel Survey and was the Starmine Healthcare Stockpicker of the year in 2006 and 2013.
“Liz is a highly regarded figure in the Life Science sector. We are delighted someone of her calibre has joined the team. We understand the challenges faced by Life Science companies engaging a non-specialist investor audience. Liz’s insight and experience will be instrumental in helping us deliver the outcomes our clients are seeking.”
Iain Daly, Radnor Capital Partners
“I am excited to be helping the Radnor Capital team grow their presence in the Life Science sector. Their focus on bridging the gap between companies and investors is ideally suited to the sector. Everyone knows the specialist investors; the generalists are harder to reach.”
+44 (0)20 3897 1832